News
ENOV
22.59
+3.67%
0.80
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Viridian Therapeutics (VRDN) and Enovis (ENOV)
TipRanks · 4d ago
Weekly Report: what happened at ENOV last week (0126-0130)?
Weekly Report · 4d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enovis (ENOV), Guardian Pharmacy Services, Inc. Class A (GRDN) and Biogen (BIIB)
TipRanks · 01/27 11:40
Weekly Report: what happened at ENOV last week (0119-0123)?
Weekly Report · 01/26 10:24
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Barchart · 01/23 07:30
Assessing Enovis (ENOV) Valuation After Recent Weak Share Price Performance
Simply Wall St · 01/22 21:23
Top 3 Health Care Stocks That Could Blast Off This Month
Benzinga · 01/21 11:41
Weekly Report: what happened at ENOV last week (0112-0116)?
Weekly Report · 01/19 10:31
March 20th Options Now Available For Enovis (ENOV)
NASDAQ · 01/15 16:00
A Look At Enovis (ENOV) Valuation After Naming Oliver Engert As Chief Administrative Officer
Simply Wall St · 01/14 09:48
Enovis: Discounted Valuation and Improving Profitability Support Buy Rating Despite Near-Term Growth Headwinds
TipRanks · 01/13 11:45
BTIG Reaffirms Their Buy Rating on Enovis (ENOV)
TipRanks · 01/13 11:12
Reported Earlier: Enovis Revises 2025 Outlook, Expects Adjusted EPS Range $3.25 - $3.35, Revenue Range $2.24B - $2.25B
Benzinga · 01/12 19:09
Enovis sees FY25 sales $2.24B-$2.25B, consensus $2.26B
TipRanks · 01/12 17:06
Enovis sees 50bps aEBITDA expansion in 2026, mid-single digit organic growth
TipRanks · 01/12 17:06
Enovis raises FY25 adjusted EPS view to $3.25-$3.35 from $3.10-$3.25
TipRanks · 01/12 17:06
Enovis free cash flow set to improve in FY26, says Evercore ISI
TipRanks · 01/12 17:05
Enovis to Present at J.P. Morgan Healthcare Conference
TipRanks · 01/12 12:21
Weekly Report: what happened at ENOV last week (0105-0109)?
Weekly Report · 01/12 10:30
Is Enovis (ENOV) Elevating Execution Risk Management With Its New Chief Administrative Officer?
Simply Wall St · 01/10 20:16
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).